2 Best Biotech Stocks to Buy in July
The pharmaceutical industry can be especially lucrative for investors. Drugmakers sell medicines on patents lasting longer than a decade and are critical to the well-being of patients, which builds in a great deal of pricing power.
But investors also need to be careful when selecting pharmaceutical stocks, too. When major patents expire and competition enters the mix, businesses can suffer greatly if they aren't prepared.
Here are two giant drugmakers for income investors to consider buying this month that look equipped to continue thriving in the future.
Source Fool.com
